featured
Ixekizumab in Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
N. Engl. J. Med 2016 Jun 08;[EPub Ahead of Print], KB Gordon, A Blauvelt, KA Papp, RG Langley, T Luger, M Ohtsuki, K Reich, D Amato, SG Ball, DK Braun, GS Cameron, J Erickson, RJ Konrad, TM Muram, BJ Nickoloff, OO Osuntokun, RJ Secrest, F Zhao, L Mallbris, CL LeonardiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.